Download PDF
CC BY-NC-ND 4.0 · J Lab Physicians 2021; 13(03): 231-237
DOI: 10.1055/s-0041-1730880
Original Article

Candiduria—Study of Virulence Factors and Its Antifungal Susceptibility Pattern in Tertiary Care Hospital

Subramanian Pramodhini
1   Department of Microbiology, Mahatma Gandhi Medical College and Research Institute, Sri Balaji Vidyapeeth (deemed to be university), Puducherry, India
,
Sreenivasan Srirangaraj
1   Department of Microbiology, Mahatma Gandhi Medical College and Research Institute, Sri Balaji Vidyapeeth (deemed to be university), Puducherry, India
,
Joshy Maducolil Easow
1   Department of Microbiology, Mahatma Gandhi Medical College and Research Institute, Sri Balaji Vidyapeeth (deemed to be university), Puducherry, India
› Author Affiliations
› Further Information
   Permissions and Reprints

Abstract

Background The increased incidence of candiduria in hospitalized patients is due to the use of indwelling devices, long-term antibiotics, parenteral nutrition, and immunocompromised status of the patient. In this study, an attempt was made to speciate, characterize, and determine the antifungal susceptibility pattern of Candida isolated from urinary tract infections (UTIs).

Materials and Methods A total of 70 Candida isolates were obtained from urine samples. The isolated Candida species were studied for the production of virulence factors like phospholipase, protease activities, hemolysin, and biofilm production. Antifungal susceptibility testing of the isolated yeasts was done using Mueller-Hinton agar supplemented with 0.5 mg/mL methylene blue by E-test method for amphotericin B, fluconazole, caspofungin, and voriconazole.

Results Out of 70 isolates, Candida tropicalis was the most frequently isolated species (65.7%), followed by Candida albicans (14.3%), Candida glabrata (7.1%), Candida krusei (5.7%), Candida parapsilosis (4.3%), and Candida dubliniensis (2.9%). A total of 37.1% were biofilm producers, 62.9% showed proteinase activity, 38.6% were phospholipase positive, and 58.6% isolates showed hemolytic activity. Antifungal susceptibility profile of Candida species showed 38.6, 25.7, 15.7, and 12.9% resistance to amphotericin B, fluconazole, caspofungin, and voriconazole, respectively.

Conclusion A rising trend in isolation of non-albicans Candida from urinary isolates was noticed, which was statistically significant when comparing catheterized and noncatheterized urinary isolates from our study. However, there was no statistically significant difference when different virulence factor expressions were compared among Candida spp. isolated from catheterized and noncatheterized urinary samples. Due to this rise in non-albicans Candida species causing UTI that are intrinsically resistant to certain antifungal agents like azoles and increasing incidence of antifungal resistance, it is essential to monitor the antifungal susceptibility profile of Candida species causing candiduria.

Keywords

virulence - biofilm - proteinase - phospholipase - hemolysin


Publication History

Article published online:
28 June 2021

© 2021. The Indian Association of Laboratory Physicians. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Kauffman CA, Fisher JF, Sobel JD, Newman CA. Candida urinary tract infections—diagnosis. Clin Infect Dis 2011; 52 (Suppl. 06) S452-S456
    CrossrefPubMedGoogle Scholar
  • 2 Agarwal S, Manchanda V, Verma N, Bhalla P. Yeast identification in routine clinical microbiology laboratory and its clinical relevance. Indian J Med Microbiol 2011; 29 (02) 172-177
    CrossrefPubMedGoogle Scholar
  • 3 Larone DH. Medically Important Fungi: A Guide to Identification. 5th ed. Washington DC: ASM press 2011
  • 4 Tsang CSP, Chu FCS, Leung WK, Jin LJ, Samaranayake LP, Siu SC. Phospholipase, proteinase and haemolytic activities of Candida albicans isolated from oral cavities of patients with type 2 diabetes mellitus. J Med Microbiol 2007; 56 (Pt 10) 1393-1398
    CrossrefPubMedGoogle Scholar
  • 5 Samaranayake LP, Raeside JM, MacFarlane TW. Factors affecting the phospholipase activity of Candida species in vitro. Sabouraudia 1984; 22 (03) 201-207
    CrossrefPubMedGoogle Scholar
  • 6 Mohandas V, Ballal M. Distribution of Candida species in different clinical samples and their virulence: biofilm formation, proteinase and phospholipase production: a study on hospitalized patients in southern India. J Glob Infect Dis 2011; 3 (01) 4-8
    CrossrefPubMedGoogle Scholar
  • 7 Staib F. Serum-proteins as nitrogen source for yeastlike fungi. Sabouraudia 1965; 4 (03) 187-193
    CrossrefPubMedGoogle Scholar
  • 8 Manns JM, Mosser DM, Buckley HR. Production of a hemolytic factor by Candida albicans. Infect Immun 1994; 62 (11) 5154-5156
    CrossrefPubMedGoogle Scholar
  • 9 Branchini ML, Pfaller MA, Rhine-Chalkberg J, Frempong T, Isenberg HD. Genotype variation and slime production among blood and catheter isolates of C. parapsilosis . J Clin Microbiol 1994; 32: 452-456
    CrossrefPubMedGoogle Scholar
  • 10 Clinical and Laboratory Standards Institute. Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts. 3rd ed. CLSI document M44. Wayne, PA: Clinical and Laboratory Standards Institute 2020
  • 11 Lundstrom T, Sobel J. Nosocomial candiduria: a review. Clin Infect Dis 2001; 32 (11) 1602-1607
    CrossrefPubMedGoogle Scholar
  • 12 Guler S, Ural O, Findik D, Arslan U. Risk factors for nosocomial candiduria. Saudi Med J 2006; 27 (11) 1706-1710
    PubMedGoogle Scholar
  • 13 Gharanfoli A, Mahmoudi E, Torabizadeh R, Katiraee F, Faraji S. Isolation, characterization, and molecular identification of Candida species from urinary tract infections. Curr Med Mycol 2019; 5 (02) 33-36
    PubMedGoogle Scholar
  • 14 Marak MB, Dhanashree B. Isolated from Clinical Samples. Antifungal susceptibility and biofilm production of Candida spp. Int J Microbiol 2018; 2018: 7495218
    CrossrefPubMedGoogle Scholar
  • 15 Sajjan AC, Mahalakshmi VV, Hajare D. Prevalence and antifungal susceptibility of Candida species isolated from patients attending tertiary care hospital. IOSR J Dent Med Sci 2014; 13 (05) 44-49
    CrossrefGoogle Scholar
  • 16 Passos XS, Sales WS, Maciel PJ. et al Candida colonization in intensive care unit patients’ urine. Mem Inst Oswaldo Cruz 2005; 100 (08) 925-928
    CrossrefPubMedGoogle Scholar
  • 17 Tomczak H, Szałek E, Grześkowiak E. The problems of urinary tract infections with Candida spp. aetiology in women. Postepy Hig Med Dosw 2014; 68: 1036-1039
    CrossrefPubMedGoogle Scholar
  • 18 Jain M, Dogra V, Mishra B, Thakur A, Loomba PS, Bhargava A. Candiduria in catheterized intensive care unit patients: emerging microbiological trends. Indian J Pathol Microbiol 2011; 54 (03) 552-555
    CrossrefPubMedGoogle Scholar
  • 19 Lata RP, Jayshri DP, Palak B, Sanjay DR, Parul DS. Prevalence of Candida infection and its antifungal susceptibility pattern in tertiary care hospital, Ahmedabad. Natl J Med Res 2012; 2: 439-441
    Google Scholar
  • 20 Achkar JM, Fries BC. Candida infections of the genitourinary tract. Clin Microbiol Rev 2010; 23 (02) 253-273
    CrossrefPubMedGoogle Scholar
  • 21 Schaller M, Borelli C, Korting HC, Hube B. Hydrolytic enzymes as virulence factors of Candida albicans. Mycoses 2005; 48 (06) 365-377
    CrossrefPubMedGoogle Scholar
  • 22 Alenzi FQB. Virulence factors of Candida species isolated from patients with urinary tract infection and obstructive uropathy. Pak J Med Sci 2016; 32 (01) 143-146
    PubMedGoogle Scholar
  • 23 Borst A, Fluit AC. High levels of hydrolytic enzymes secreted by Candida albicans isolates involved in respiratory infections. J Med Microbiol 2003; 52 (Pt 11) 971-974
    CrossrefPubMedGoogle Scholar
  • 24 Sachin CD, Ruchi K, Santosh S. In vitro evaluation of proteinase, phospholipase and haemolysin activities of Candida species isolated from clinical specimens. Int J Med Biomed Res 2012; 1 (02) 153-157
    CrossrefGoogle Scholar
  • 25 Udayalaxmi JS, Jacob S, D’Souza D. Comparison between virulence factors of Candida albicans and non-Albicans species of Candida isolated from genitourinary tract. J Clin Diagn Res 2014; 8 (11) DC15-DC17
    PubMedGoogle Scholar
  • 26 Yenisehirli G, Bulut N, Yenisehirli A, Bulut Y. In vitro susceptibilities of Candida albicans isolates to antifungal agents in Tokat, Turkey. Jundishapur J Microbiol 2015; 8 (09) e28057
    CrossrefPubMedGoogle Scholar